1. Home
  2. BBIO vs EMBJ Comparison

BBIO vs EMBJ Comparison

Compare BBIO & EMBJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BridgeBio Pharma Inc.

BBIO

BridgeBio Pharma Inc.

HOLD

Current Price

$74.18

Market Cap

14.4B

Sector

Health Care

ML Signal

HOLD

EMBJ

Embraer S.A.

N/A

Current Price

$63.39

Market Cap

11.8B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
BBIO
EMBJ
Founded
2015
1969
Country
United States
Brazil
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Aerospace
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
14.4B
11.8B
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
BBIO
EMBJ
Price
$74.18
$63.39
Analyst Decision
Strong Buy
Analyst Count
21
0
Target Price
$76.24
N/A
AVG Volume (30 Days)
2.0M
865.8K
Earning Date
10-29-2025
11-04-2025
Dividend Yield
N/A
0.08%
EPS Growth
N/A
N/A
EPS
N/A
0.45
Revenue
$353,780,000.00
$7,746,796,250.00
Revenue This Year
$128.44
N/A
Revenue Next Year
$76.14
$10.84
P/E Ratio
N/A
$138.01
Revenue Growth
62.46
31.44
52 Week Low
$25.34
$34.88
52 Week High
$76.51
$67.44

Technical Indicators

Market Signals
Indicator
BBIO
EMBJ
Relative Strength Index (RSI) 62.39 N/A
Support Level $72.73 N/A
Resistance Level $76.51 N/A
Average True Range (ATR) 2.37 0.00
MACD -0.30 0.00
Stochastic Oscillator 66.40 0.00

Price Performance

Historical Comparison
BBIO
EMBJ

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

About EMBJ Embraer S.A.

Embraer SA based in Sao Paulo, Brazil, manufacturer of jets. Its focus is to achieve customer satisfaction with and services addressing the commercial airline, executive jets, and defense and security markets. It has developed a customer-centric technology-driven portfolio of commercial aviation products and services that allows it to build long-term relationships with clients in the commercial aviation, executive jets, and defense and security markets. It operates through the various segments namely Commercial Aviation, Defense and Security, Executive Aviation, Service and Support, and Other Segments. The company generates maximum revenue from the Commercial Aviation segment.

Share on Social Networks: